factual

Large pharma deals are transactional and milestone-driven

Large pharma partnerships are typically transactional and milestone-driven with little flexibility, while academic groups find Argenx's collaboration far more exploratory and open.

factualpending

Speaker

Julia

Evidence Quote

“It's very much driven by milestones. There is not so much flexibility.”

Source

Argenx: Changing Lives with Llamas— Business Breakdowns
Created: 11/17/2026, 3:39:21 AM

Your notes

Loading notes...